SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

SCHEDULE OF RESTATEMENT OF CONSOLIDATED BALANCE SHEETS

The following tables present the effects of the Restatement on the Company’s consolidated balance sheets as of December 31, 2023 and 2022:

		As Previously				Restatement				As
		December 31, 2023
		As Previously				Restatement				As
		Stated				Adjustments				Restated

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Derivative liabilities		$	-			$	1,543,953			$	1,543,953
Total current liabilities		$	1,063,392			$	1,543,953			$	2,607,345
Total liabilities		$	1,063,392			$	1,543,953			$	2,607,345
Stockholders’ equity
Additional paid-in capital		$	178,590,256			$	(21,901,000	)		$	156,689,256
Accumulated deficit		$	(167,056,381	)		$	20,357,047			$	(146,699,334	)
Total stockholders’ equity		$	11,548,328			$	(1,543,953	)		$	10,004,375
Total liabilities and stockholders’ equity		$	12,611,720			$	-			$	12,611,720

		As Previously				Restatement				As
		December 31, 2022
		As Previously				Restatement				As
		Stated				Adjustments				Restated

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Derivative liabilities		$	-			$	5,541,733			$	5,541,733
Total current liabilities		$	440,302			$	5,541,733			$	5,982,035
Total liabilities		$	602,619			$	5,541,733			$	6,144,352
Stockholders’ equity
Additional paid-in capital		$	168,457,418			$	(21,901,000	)		$	146,556,418
Accumulated deficit		$	(152,640,897	)		$	16,359,267			$	(136,281,630	)
Total stockholders’ equity		$	15,832,072			$	(5,541,733	)		$	10,290,339
Total liabilities and stockholders’ equity		$	16,434,691			$	-			$	16,434,691

SCHEDULE OF RESTATEMENT OF CONSOLIDATED STATEMENTS OF OPERATIONS

The following tables present the effects of the Restatement on the Company’s consolidated statements of operations for the years ended December 31, 2023 and 2022:

		As Previously				Restatement				As
		For the Year Ended
		December 31, 2023
		As Previously				Restatement				As
		Stated				Adjustments				Restated

Change in fair value of derivative liabilities		$	-			$	(3,997,780	)		$	(3,997,780	)
Total other income		$	(805,290	)		$	(3,997,780	)		$	(4,803,070	)
Net (loss) income		$	(14,415,484	)		$	3,997,780			$	(10,417,704	)

Earnings (loss) per share - basic and diluted		$	(3.42	)		$	0.95			$	(2.47	)

		As Previously				Restatement				As
		For the Year Ended
		December 31, 2022
		As Previously				Restatement				As
		Stated				Adjustments				Restated

Change in fair value of derivative liabilities		$	-			$	(5,272,473	)		$	(5,272,473	)
Total other income		$	(479,256	)		$	(5,272,473	)		$	(5,751,729	)
Net (loss) income		$	(18,494,769	)		$	5,272,473			$	(13,222,296	)

Loss per share:
Earnings (loss) per share - basic and diluted		$	(5.11	)		$	1.46			$	(3.65	)

SCHEDULE OF RESTATEMENT OF CONSOLIDATED STATEMENTS OF CHANGE IN STOCKHOLDERS’ EQUITY

The following tables present the effects of the Restatement on the Company’s consolidated statements of changes in stockholders’ equity for the years ended December 31, 2023 and 2022:


Balance - December 31, 2023 (as previously reported)		$	178,590,256			$	(167,056,381	)		$	11,548,328

Adjustment due to cumulative error correction			(21,901,000	)			16,359,267				(5,541,733	)

Change in fair value of derivative liability			-				3,997,780				3,997,780

Balance - December 31, 2023 (as restated)		$	156,689,256			$	(146,699,334	)		$	10,004,375

Balance - December 31, 2022 (as previously reported)		$	168,457,418			$	(152,640,897	)		$	15,832,072

Adjustment due to cumulative error correction			(21,901,000	)			11,086,794				(10,814,206	)

Change in fair value of derivative liability			-				5,272,473				5,272,473

Balance - December 31, 2022 (as restated)		$	146,556,418			$	(136,281,630	)		$	10,290,339

SCHEDULE OF RESTATEMENT OF CONSOLIDATED STATEMENT OF CASH FLOWS

The following tables present the effects of the Restatement on the Company’s consolidated statements of cash flows for the years ended December 31, 2023 and 2022:

		As Previously				Restatement				As
		December 31, 2023
		As Previously				Restatement				As
		Stated				Adjustments				Restated

Cash Flows From Operating Activities:
Net (loss) income		$	(14,415,484	)		$	3,997,780			$	(10,417,704	)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Change in fair value of derivative liability		$	-			$	(3,997,780	)		$	(3,997,780	)
Net Cash Used In Operating Activities		$	(6,430,211	)		$	-			$	(6,430,211	)

		As Previously				Restatement				As
		December 31, 2022
		As Previously				Restatement				As
		Stated				Adjustments				Restated

Cash Flows From Operating Activities:
Net (loss) income		$	(18,494,769	)		$	5,272,473			$	(13,222,296	)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Change in fair value of derivative liability		$	-			$	(5,272,473	)		$	(5,272,473	)
Net Cash Used In Operating Activities		$	(5,913,100	)		$	-			$	(5,913,100	)

SCHEDULE OF WEIGHTED AVERAGE DILUTIVE COMMON SHARES

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss position even though the exercise price could be less than the average market price of the common shares:

		For the Years Ended
		December 31,
		2023				2022
Stock options			1,466,892				864,639
Warrants			4,791,019				4,791,082
Unvested RSUs			97,827				201,870
Convertible Preferred Stock			1,398,158				1,518,158
Total			7,753,896				7,375,749